Novo Nordisk has signed a Memorandum of Understanding (MoU) with TEDA Administrative Commission, agreeing to invest appr...
The Hong Kong Polytechnic University (PolyU) has signed a Memorandum of Understanding (MoU) with the Peking Union Medica...
Cornerstone Robotics has announced the launch of its first formal clinical investigation of its Hong Kong-developed surg...
China-based CStone Pharmaceuticals has announced an exclusive partnership with Istituto Gentili, a leading European biop...
Dr Jeremy Teoh Yuen-chun, Assistant Dean (External Affairs) and Associate Professor from the Division of Urology in the ...
The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) and The Hong Kong Sports Institute ...
Brii Biosciences Limited, a biotechnology company developing therapies to improve patient health and choice across disea...
Switzerland-headquartered Ypsomed has opened its first dedicated production site in China. The new facility, located in ...
WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRDMO) in China, has an...
EVA Pharma, one of the leading pharmaceutical companies driving healthcare innovation and access across the Middle East ...
Innovent Biologics, Inc. has announced that China's National Medical Products Administration (NMPA) has approved mazduti...
Bayer and Tsinghua University (THU) have announced the signing of the sixth phase of the collaboration agreement, aiming...
Why CPHI & PMEC China Matters Held at the Shanghai New International Expo Center from 23 to 26 June 2025, CPHI &...
Bridging China and the Middle East to Strengthen Regional Supply chains and Impact Millions of Cancer Patients On the ...
Apeloa Pharmaceutical, a subsidiary of Hengdian Group, is a leading Chinese and global pharmaceutical firm and a ke...
CPHI & PMEC China kickstarted with a grandure cenremoney at Shanghai New International Expo Center convening the int...
China-based startup XtalPi, a global leader in artificial intelligence (AI)- and robotics-powered drug and materials dis...
CanSino Biologics Inc. has developed and launched its 13-valent pneumococcal conjugate vaccine, trade name "iPneucia", o...
